Discover how much money can be saved in your clinical trial!

Duplicate Subjects In Clinical Trials and Decentralized Clinical Trials. Unique Issues With Professional Research Subjects

Interest in decentralized clinical trials has increased and has become quite popular. The adoption of these methods became acutely more appealing and necessary during the pandemic. Many research sites and clinical trial sponsors have adopted decentralized clinical trial methods. But decentralized clinical trials also come with unique challenges. To keep clinical trials safe, compliant, and effective, …

Read more

The Professional Research Subject Problem In Clinical Trials

Clinical research patients are compensated for their participation in clinical trials. In some therapeutic areas and types of clinical trials, the compensation for enrolling in one or more clinical trials or at multiple research sites is enough to influence patients to join more than one contemporaneously and expose themselves to multiple investigational products or multiple …

Read more

RESEARCH SITES AND SPONSORS COOPERATE TO PREVENT PROFESSIONAL RESEARCH SUBJECTS IN CNS CLINICAL TRIALS BY USING VERIFIED CLINICAL TRIALS

Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …

Read more

Strategies To Proactively Detect And Prevent Professional Research Subjects With Verified Clinical Trials Research Subject Database Registry

Clinical trials around the world face challenges from professional research subjects or dual enrollment in clinical trials. One group of subjects that have high rates of participation in clinical research are subjects who enroll in multiple trials for the purpose of generating income through study payments or using clinical trials as medical care. These subjects …

Read more

Sees Progress in the Understanding

Verified Clinical Trials Sees Progress In The Understanding and Acceptance of Duplicate Subjects In Clinical Trials

We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials  or professional research subjects over the past few years.  Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …

Read more

Screen Shot 2019 07 26 at 9.37.51 AM

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and  as well as other protocol violations. The workshop …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more